Samdolite Pharmaceuticals presents new prodrugs of cromoglicic acid

Dec. 19, 2023

Samdolite Pharmaceuticals LLC has divulged prodrugs of cromoglicic acid reported to be useful for the treatment of inflammation and dermatological disorders.

BioWorld Science Dermatologic Patents

Today's news in brief

BioWorld

BioWorld briefs for Sept. 25, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Sept. 24, 2025.

3D molecular view of liquid-liquid phase separation

Condensates and innate immunity in Clarivate’s Citation Laureates

BioWorld Science

Clarivate plc has unveiled the 2025 Citation Laureates. Widely considered a predictor of the Nobel Prizes, this recognition has highlighted the discovery of...

Human Cell Atlas discovers new targets in skin fibroblast subtypes

BioWorld Science

The Human Cell Atlas project has delivered a fresh tranche of data mapping fibroblasts in healthy and diseased skin and pointing to drug targets with potential in...

Illustration of antibodies attacking nerve cells

Aera Therapeutics selects AERA-109 for autoimmune diseases

BioWorld Science

Aera Therapeutics Inc. has nominated AERA-109, a targeted in vivo CAR T therapy designed to treat multiple B cell-mediated autoimmune diseases, as the company’s...